The bolus is a simple bivalent product ... but then there were these unforeseen events, the syringe shortage in mid-2022, the contamination events, and you could not take that, you could not ...
TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS ...
The prefilled syringe which opens the door for self-administration in the U.S., is expected to be a key driver of this growth in 2025 for both MG and CIDP. It is incredible to see the strong early ...
You mentioned product mix, I totally agree with that. Simply Tri-Shield is more expensive to produce than the bolus. The bolus is a simple bivalent product, a single production train. The Tri ...
ImmuCell Corporation, a small-cap biotech company with a market capitalization of $46.52 million, reported significant sales growth in the fourth quarter of 2024, with revenue reaching $7.8 million.
The published evidence identified also showed that insulin administration via NovoPen ® devices was for most patients easier, more convenient and quicker than with conventional syringes and that ...
ImmuCell Corporation, a small-cap biotech company with a market capitalization of $46.52 million, reported significant sales growth in the fourth quarter of 2024, with revenue reaching $7.8 million.
They instead recommend alternative methods, such as basal-bolus insulin. However, some healthcare professionals may still temporarily use sliding scale insulin therapy for people with noncritical ...
Am J Health Syst Pharm. 2008;65(24):2347-2357. Administer medications via the oral route when possible. Determine the enteral feeding tube size (e.g., small bore or large bore), insertion site (e ...
I was admitted to the hospital for a week of stabilization and education; I was given an orange, a syringe, and a vial, and was taught how to draw a dose and inject the orange. I then had to muster ...
This study provides a valuable approach to image and analyze in vivo metabolic flux through glucose turnover kinetics in glioblastoma tumor microenvironments. The evidence for the method's validity is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results